Modelling Disease Progression of Multiple Sclerosis in a South Wales Cohort
Neuroepidemiology · 2024
DOI: 10.1159/000536427 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuroepidemiology, 2024. Verfasst von Emeka C Uzochukwu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, UK. Hauptthemen laut MEDLINE: Disease Progression, Multiple Sclerosis, Age of Onset. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust.
Abstract (Originalsprache)
Objectives
The objective of this study was to model multiple sclerosis (MS) disease progression and compare disease trajectories by sex, age of onset, and year of diagnosis. Study Design and Setting: Longitudinal EDSS scores (20,854 observations) were collected for 1,787 relapse-onset MS patients at MS clinics in South Wales and modelled using a multilevel model (MLM). The MLM adjusted for covariates (sex, age of onset, year of diagnosis, and disease-modifying treatments), and included interactions between baseline covariates and time variables.
Results
The optimal model was truncated at 30 years after disease onset and excluded EDSS recorded within 3 months of relapse. As expected, older age of onset was associated with faster disease progression at 15 years (effect size (ES): 0.75; CI: 0.63, 0.86; p: <0.001) and female-sex progressed more slowly at 15 years (ES: −0.43; CI: −0.68, −0.18; p: <0.001). Patients diagnosed more recently (defined as 2007–2011 and >2011) progressed more slowly than those diagnosed historically (<2006); (ES: −0.46; CI: −0.75, −0.16; p: 0.006) and (ES: −0.95; CI: −1.20, −0.70; p: <0.001), respectively.
Conclusion
We present a novel model of MS outcomes, accounting for the non-linear trajectory of MS and effects of baseline covariates, validating well-known risk factors (sex and age of onset) associated with disease progression. Also, patients diagnosed more recently progressed more slowly than those diagnosed historically.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, UK.
- Department of Neurology, Royal Gwent Hospital, Newport, UK.
- Department of Neurology, University Hospital of Wales, Cardiff, UK.
- Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, UK.
- Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
Förderung
- Wellcome Trust
Zitieren
APA
Uzochukwu, E. C., Harding, K. E., Hrastelj, J., Kreft, K. L., Holmans, P., Robertson, N. P., Tallantyre, E. C., & Lawton, M. (2024). Modelling Disease Progression of Multiple Sclerosis in a South Wales Cohort. Neuroepidemiology. https://doi.org/10.1159/000536427
Vancouver
Uzochukwu EC, Harding KE, Hrastelj J, Kreft KL, Holmans P, Robertson NP, et al. Modelling Disease Progression of Multiple Sclerosis in a South Wales Cohort. Neuroepidemiology. 2024. doi:10.1159/000536427
BibTeX
@article{Uzochukwu2024,
author = {Uzochukwu, Emeka C and Harding, Katharine E and Hrastelj, James and Kreft, Karim L and Holmans, Peter and Robertson, Neil P and Tallantyre, Emma C and Lawton, Michael},
title = {Modelling Disease Progression of Multiple Sclerosis in a South Wales Cohort},
journal = {Neuroepidemiology},
year = {2024},
doi = {10.1159/000536427}
}
EUVIMED